MENU
TransCode Therapeutics (RNAZ) Ownership - Who owns TransCode Therapeutics?
Profile
Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.74M
P/E Ratio
0.00
Total Cash
3.35M
Projected Growth
N/A
Total Debt
227.25K
Revenue
N/A
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RNAZ
Capitalization
4.74M
P/E Ratio
0.00
Risk (Beta)
0.43
Dividend Yield
N/A
Total Cash
3.36M
Total Cash/Share
0.19
Total Debt
227K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.32M
P/B Ratio
3.59
Cash Flow
N/A
Earnings
268.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
727
Current Ratio
1.25
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-17.29M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-334.48
Shares Held By Institutions
160K
Shares Outstanding - Current
17.3M
Total Liabilities
3.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-95.833
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
6 Liberty Square
Phone
+1 857 837-3099
Employees
10
Web
https://www.transcodetherapeutics.com